Point72 Europe London LLP Has $28.92 Million Stock Position in KKR & Co. Inc. (NYSE:KKR)

Point72 Europe London LLP lowered its position in KKR & Co. Inc. (NYSE:KKR) by 2.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 195,549 shares of the asset manager’s stock after selling 3,900 shares during the period. KKR & Co. Inc. comprises 1.7% of Point72 Europe London LLP’s holdings, making the stock its 17th largest position. Point72 Europe London LLP’s holdings in KKR & Co. Inc. were worth $28,924,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in shares of KKR & Co. Inc. by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 56,687,516 shares of the asset manager’s stock worth $8,384,650,000 after acquiring an additional 441,817 shares in the last quarter. Geode Capital Management LLC grew its position in shares of KKR & Co. Inc. by 3.4% in the 4th quarter. Geode Capital Management LLC now owns 14,047,900 shares of the asset manager’s stock valued at $2,073,624,000 after purchasing an additional 458,048 shares during the period. FMR LLC grew its position in shares of KKR & Co. Inc. by 6.7% in the 4th quarter. FMR LLC now owns 12,003,389 shares of the asset manager’s stock valued at $1,775,421,000 after purchasing an additional 752,056 shares during the period. Norges Bank bought a new stake in KKR & Co. Inc. during the 4th quarter worth approximately $1,435,314,000. Finally, Nuveen Asset Management LLC increased its stake in KKR & Co. Inc. by 106.2% during the 4th quarter. Nuveen Asset Management LLC now owns 6,584,370 shares of the asset manager’s stock worth $973,894,000 after purchasing an additional 3,391,581 shares in the last quarter. Institutional investors and hedge funds own 76.26% of the company’s stock.

Insider Buying and Selling at KKR & Co. Inc.

In other KKR & Co. Inc. news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $32.96, for a total transaction of $197,760,000.00. Following the transaction, the insider now owns 19,260,971 shares of the company’s stock, valued at $634,841,604.16. The trade was a 23.75% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Robert W. Scully acquired 13,250 shares of the company’s stock in a transaction on Tuesday, May 6th. The stock was acquired at an average price of $113.49 per share, for a total transaction of $1,503,742.50. Following the purchase, the director now directly owns 13,250 shares of the company’s stock, valued at approximately $1,503,742.50. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 39.34% of the company’s stock.

KKR & Co. Inc. Stock Up 1.7%

KKR stock opened at $129.02 on Thursday. The company has a market cap of $114.60 billion, a price-to-earnings ratio of 38.74, a P/E/G ratio of 1.00 and a beta of 1.91. KKR & Co. Inc. has a twelve month low of $86.15 and a twelve month high of $170.40. The business has a 50 day moving average price of $111.59 and a two-hundred day moving average price of $135.88. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.82.

KKR & Co. Inc. (NYSE:KKR) last released its quarterly earnings data on Thursday, May 1st. The asset manager reported $1.15 EPS for the quarter, beating the consensus estimate of $1.13 by $0.02. KKR & Co. Inc. had a return on equity of 6.20% and a net margin of 14.31%. The company had revenue of $1.77 billion during the quarter, compared to the consensus estimate of $1.71 billion. During the same quarter in the prior year, the firm posted $0.97 EPS. The firm’s revenue for the quarter was down 67.8% compared to the same quarter last year. Analysts anticipate that KKR & Co. Inc. will post 5.19 EPS for the current fiscal year.

KKR & Co. Inc. Increases Dividend

The company also recently declared a dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th will be given a dividend of $0.185 per share. This is a positive change from KKR & Co. Inc.’s previous dividend of $0.17. This represents a yield of 0.64%. The ex-dividend date of this dividend is Monday, May 12th. KKR & Co. Inc.’s dividend payout ratio is 31.22%.

Analysts Set New Price Targets

Several research firms have recently weighed in on KKR. Barclays upped their price target on shares of KKR & Co. Inc. from $129.00 to $141.00 and gave the company an “overweight” rating in a report on Friday, May 2nd. HSBC raised shares of KKR & Co. Inc. from a “hold” rating to a “buy” rating and cut their price objective for the company from $170.00 to $119.00 in a research report on Tuesday, April 15th. Keefe, Bruyette & Woods increased their target price on KKR & Co. Inc. from $129.00 to $131.00 and gave the stock an “outperform” rating in a report on Friday, May 2nd. Morgan Stanley upgraded KKR & Co. Inc. from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $120.00 to $150.00 in a report on Wednesday. Finally, Citigroup reduced their price objective on KKR & Co. Inc. from $177.00 to $132.00 and set a “buy” rating for the company in a research report on Tuesday, April 8th. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, KKR & Co. Inc. currently has a consensus rating of “Buy” and an average price target of $149.14.

About KKR & Co. Inc.

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.